Management

This page includes content on healthcare management, including health system, hospital, department and clinic business management and administration. Areas of focus are on cardiology and radiology department business administration. Subcategories covered in this section include healthcare economics, reimbursement, leadership, mergers and acquisitions, policy and regulations, practice management, quality, staffing, and supply chain.

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics
US Radiology Specialists backer Welsh, Carson, Anderson & Stowe blasted the proposed order Friday, labeling it as symbolic and politically motivated.
Congressional candidate physician sues hospital and doctor for death of father
Some of the claims in the lawsuit, brought against Novant Health by Kyle Horton, MD, are backed by a report from the North Carolina Department of Health and Human Services.
DEA wants to permanently anchor some COVID-era prescription regulations
The Drug Enforcement Administration is proposing the adoption of some COVID-era prescription practices around certain controlled substances. The agency published a framework to guide any such changes Jan. 17.
FDA regulator examines AI's growing influence in cardiology
Stephen Browning, the FDA's assistant director of hemodynamics and heart failure diagnostics, spoke with Cardiovascular Business about the agency's perspective on AI-enabled cardiovascular devices and many other topics.
RadNet sees potential midsize and larger acquisitions on its horizon
Leaders with the Los Angeles-based, publicly traded imaging center operator spoke Jan. 15 at the 43rd annual JP Morgan Healthcare Conference in San Francisco.

RadNet joins hospital giant HCA and others in coalition to address woeful cancer screening rate

The consortium of cancer care stakeholders recently held a launch event, with others involved including the ACR, Johnson & Johnson, and drug company AstraZeneca.

AI and medical imaging data firm Flywheel raises $54M in series D financing

Bayer AG's former CEO is joining the startup's board, expressing excitement about the prospect of using the platform to develop new drugs.

Cardiology group faces class-action lawsuit after cyberattack exposed patients’ personal data

Patients learned that their names, social security numbers, banking numbers and credit card information were all potentially exposed as a result of the attack.

Colchicine Lodoco Agepha Pharma price cost

What will Lodoco cost? Looking ahead after FDA’s historic approval of colchicine for CVD

“Our pricing strategy for Lodoco is focused on helping to ensure access to as many people as possible,” an executive with Agepha Pharma told Cardiovascular Business.

radiologist radiology pay compensation money dollar

Radiologist is the highest paying job in these 4 states

Those include the nation’s most populace state, which employs 1,700 members of the specialty earning $339,140 annually.

FDA announces recall of more than 250,000 interventional devices due to risk of catheter separation

The FDA has said this is a Class I recall, which means using the devices “may cause serious injuries or death.” A total of 18 injuries have been reported so far.

FDA approves Bayer’s imaging agent Ultravist for use in contrast-enhanced mammography

The Germany-based corporation said this is the “only contrast agent approved for this indication” in America.

American College of Radiology voices support for MD tapped to lead NIH amid confirmation hearing holdup

“We must not lose momentum," ACR, the Academy for Radiology & Biomedical Imaging Research and more than 100 other organizations wrote to leaders of the U.S. Senate.

Management

Private equity radiology investor reaches agreement with FTC over alleged anticompetitive tactics

Congressional candidate physician sues hospital and doctor for death of father

DEA wants to permanently anchor some COVID-era prescription regulations

FDA regulator examines AI's growing influence in cardiology

RadNet sees potential midsize and larger acquisitions on its horizon